Expanding Global Footprint With operations and commercial offices across the US, EU, and China, Porton Pharma Solutions demonstrates strong international presence, offering opportunities for multinational collaborations and supply chain support in multiple regions.

Innovative Product Platform The recent launch of a state-of-the-art small-molecule platform in Shanghai positions Porton as a key partner for clients seeking advanced drug development and manufacturing capabilities, especially in the small-molecule sector.

Recent Facility Expansion The construction of a new crystallization and drug product facility in New Jersey indicates growth and increased capacity, providing potential opportunities for clients seeking reliable manufacturing and processing solutions in the US market.

Industry Recognition Winning awards like the Positive Endeavors Award highlights Porton’s commitment to supply chain responsibility and process innovation, making it an attractive partner for companies prioritizing sustainability and compliance.

Focused Service Offerings Porton’s end-to-end R&D and GMP manufacturing services across biologics, conjugates, and advanced therapies create sales opportunities with biotech firms and pharmaceutical companies looking for comprehensive development solutions from a trusted CDMO partner.